Filing Flows › Novartis AG (NVS) › Q2 2026
Novartis AG (NVS) Q2 2026 earnings results (second quarter 2026)
6-K filed Jul 21, 2026
Novartis AG (NVS) reported revenue of $14.4B for the second quarter 2026 (Q2 2026), +3% from a year earlier and +10% from the quarter before. Operating margin was 33.0%, net earnings $3.3B (22.6% of revenue).
Novartis AG, Q2 2026: revenue $14.4B (+2% year over year), operating margin 33.0%, net earnings $3.3B, operating cash flow $5.9B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.4B | +10% | +3% |
| Operating profit | $4.8B | +12% | -2% |
| Net earnings | $3.3B | +3% | -19% |
| Operating cash flow | $5.9B | — | -12% |
What changed
Revenue was $14.4B in Q2 2026, up 3% year over year and up 10% from the previous quarter.
Operating profit was $4.8B, a 33.0% margin (down 1.6 points year over year). Operating profit fell $0.11B even though revenue rose $0.35B versus a year earlier, so costs grew faster than sales. Total costs grew 5% against revenue growth of 3%. Net earnings were $3.3B, down 19% year over year. The effective tax rate was 0.0%.
Operating cash flow was $5.9B (down 12% year over year), 181% of net earnings. Working capital and other items added $2.6B.
Questions
What was Novartis AG's revenue in the second quarter 2026?
Novartis AG (NVS) reported revenue of $14.4B for the second quarter 2026 (Q2 2026), +3% from a year earlier and +10% from the quarter before.
Was Novartis AG profitable in the second quarter 2026?
Operating profit was $4.8B (33.0% of revenue) and net earnings $3.3B.
Source: Novartis AG 6-K on SEC EDGAR.